Distinguishing between exploratory and confirmatory preclinical research will improve translation.

Preclinical researchers confront two overarching agendas related to drug development: selecting interventions amid a vast field of candidates, and producing rigorous evidence of clinical promise for a small number of interventions. We suggest that each challenge is best met by two different, complem...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jonathan Kimmelman, Jeffrey S Mogil, Ulrich Dirnagl
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2014
Sujets:
Accès en ligne:https://doaj.org/article/835d26b2650a48708202d848d2b3fd7d
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires